Literature DB >> 7789305

Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.

Y Lerrant1, M L Kottler, F Bergametti, M Moumni, J Blumberg-Tick, R Counis.   

Abstract

It was previously established that the administration of a potent GnRH agonist such as triptorelin (D-Trp6-GnRH) induced desensitization of pituitary gonadotropic cells, resulting in decreased expression of gonadotropin beta-subunit genes and the suppression of LH and FSH synthesis and release. Binding of GnRH to the pituitary is also affected by agonist treatment. To examine the desensitizing effects of GnRH agonist on the expression of the pituitary GnRH receptor (GnRH-R) gene, male rats were given triptorelin (long-acting formulation, 300 micrograms/kg), and levels of GnRH-R messenger RNA (mRNA) were determined by Northern and dot blot hybridization to a 32P-labeled rat complementary DNA probe. Abundances of gonadotropin alpha-subunit, LH beta, and FSH beta mRNAs were examined in parallel, using appropriate probes. A rapid time-dependent decrease in the level of GnRH-R mRNA was observed in rats after triptorelin administration. A minimum residual level of mRNA, in the range of 20-25% of the initial value, was attained as early as 5 h after treatment. Levels further stabilized to 25-30% after a small transient increase to 45% on day 5. A single injection was effective for at least 30 days, after which GnRH-R mRNA levels slowly returned to normal, suggesting a progressive abolition of agonist effects. A concomitant acute depletion of mRNA levels was observed for LH beta and FSH beta (50% decrease in about 48 and 3 h, respectively), whereas the alpha-subunit message increased (rapidly reaching a level 1.8-fold that in control rats after 1-2 days). Castration induced a 3.8-fold elevation in the amounts of GnRH-R mRNA after 3 weeks, whereas alpha, LH beta, and FSH beta mRNAs increased by 6.2-, 7.9-, and 4.2-fold, respectively, compared to corresponding values in intact animals. Administration of the GnRH agonist readily prevented, for as long as 3 weeks, the stimulatory effects of castration on the GnRH-R mRNA and mRNAs for the beta-subunit of gonadotropins, but not for the alpha mRNA, which remained at a high level. When triptorelin was administered 3 weeks postoperatively, the castration-induced increase in LH beta and FSH beta was totally abolished, and no significant effect was noted on alpha-subunit mRNA. In conclusion, these data demonstrate that expression of the GnRH-R gene is subject to regulation and depends on GnRH stimulation, in a manner that indicates susceptibility to desensitizing action by the long-acting GnRH analog, triptorelin.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789305     DOI: 10.1210/endo.136.7.7789305

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix.

Authors:  Gabor Halmos; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.

Authors:  Judit E Horvath; Ana M Bajo; Andrew V Schally; Magdolna Kovacs; Francine Herbert; Kate Groot
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

3.  Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats.

Authors:  J W Kostanski; B A Dani; B Schrier; P P DeLuca
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

4.  Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.

Authors:  M Kovacs; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

5.  SET protein interacts with intracellular domains of the gonadotropin-releasing hormone receptor and differentially regulates receptor signaling to cAMP and calcium in gonadotrope cells.

Authors:  Charlotte Avet; Ghislaine Garrel; Chantal Denoyelle; Jean-Noël Laverrière; Raymond Counis; Joëlle Cohen-Tannoudji; Violaine Simon
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

6.  Regulation of GnRH I receptor gene expression by the GnRH agonist triptorelin, estradiol, and progesterone in the gonadotroph-derived cell line alphaT3-1.

Authors:  J M Weiss; S Polack; O Treeck; K Diedrich; O Ortmann
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

7.  Development of gonadotropin-releasing hormone secretion and pituitary response.

Authors:  Katarzyna M Glanowska; Laura L Burger; Suzanne M Moenter
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

8.  Predominant suppression of follicle-stimulating hormone β-immunoreactivity after long-term treatment of intact and castrate adult male rats with the gonadotrophin-releasing hormone agonist deslorelin.

Authors:  A W Smith; C S Asa; B S Edwards; W J Murdoch; D C Skinner
Journal:  J Neuroendocrinol       Date:  2012-05       Impact factor: 3.627

9.  A novel reproductive peptide, phoenixin.

Authors:  G L C Yosten; R-M Lyu; A J W Hsueh; O Avsian-Kretchmer; J-K Chang; C W Tullock; S L Dun; N Dun; W K Samson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

10.  The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.

Authors:  Joelle E Taylor; Bradley T Miller; Karen D Gray; Richard T Scott; William H Catherino; James H Segars
Journal:  Fertil Steril       Date:  2009-02-06       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.